Ognjen Tasic drives electric. His new company car: a Vivaro-e HYDROGEN. The hydrogen fuel cell drive produces electricity while it shuttles between dental practices, medical and pharmaceutical laboratories. Tasic’s expertise is the highly complex inner workings of laboratory dishwashers. And that of thermal disinfection units. For eleven years, he has been on the road as… Continue reading @Groupe PSA: OP No Compromises000495
Tag: Strategy
@VINFAST: Vingroup : Vinfast to deliver vf 8 city edition to us customers on march 1
Los Angeles, February 27, 2023 – VinFast announced it will start delivery of VF 8 City Edition vehicles to US customers beginning March 1, 2023. The delivery event will be held at the VinFasts store in California, marking VinFasts new journey in the international market.These initial deliveries are from the first shipment of 999 City… Continue reading @VINFAST: Vingroup : Vinfast to deliver vf 8 city edition to us customers on march 1
Felix Kilbertus is Pininfarina’s new Chief Creative Officer
TORINO, Italy, Feb. 28, 2023 /PRNewswire/ — Pininfarina appoints world-renowned automotive designer Felix Kilbertus as the new Chief Creative Officer. Felix will be the creative and strategic guide at Group level on all aspects of Design (Mobility, Product & Experience Design and Architecture). Reporting directly to CEO Silvio Angori, he will supervise all the Pininfarina… Continue reading Felix Kilbertus is Pininfarina’s new Chief Creative Officer
Felix Kilbertus is Pininfarina’s new Chief Creative Officer
TORINO, Italy, Feb. 28, 2023 /PRNewswire/ — Pininfarina appoints world-renowned automotive designer Felix Kilbertus as the new Chief Creative Officer. Felix will be the creative and strategic guide at Group level on all aspects of Design (Mobility, Product & Experience Design and Architecture). Reporting directly to CEO Silvio Angori, he will supervise all the Pininfarina… Continue reading Felix Kilbertus is Pininfarina’s new Chief Creative Officer
Felix Kilbertus is Pininfarina’s new Chief Creative Officer
TORINO, Italy, Feb. 28, 2023 /PRNewswire/ — Pininfarina appoints world-renowned automotive designer Felix Kilbertus as the new Chief Creative Officer. Felix will be the creative and strategic guide at Group level on all aspects of Design (Mobility, Product & Experience Design and Architecture). Reporting directly to CEO Silvio Angori, he will supervise all the Pininfarina… Continue reading Felix Kilbertus is Pininfarina’s new Chief Creative Officer
Nordic Nanovector ASA Results for the Second Half and Full Year 2022
OSLO, Norway, Feb. 28, 2023 /PRNewswire/ — Nordic Nanovector ASA (OSE: NANOV) (“Nordic Nanovector” or the “Company”) announces its results for the second half and full year 2022. A presentation by Nordic Nanovector’s interim CEO & CFO, Ludvik Sandnes will be held in-person today in Oslo and webcast live beginning at 8:30am CET – details below.… Continue reading Nordic Nanovector ASA Results for the Second Half and Full Year 2022
Volvo Cars to open new software development facility in Poland
Volvo Cars is to open a brand-new Tech Hub in Krakow, Poland’s second-largest city. The facility will be a key software development centre and play a crucial role in Volvo’s strategic ambition to be a fully electric brand by 2030 and a leader in new technology, not least through in-house software development. The Tech hub… Continue reading Volvo Cars to open new software development facility in Poland
Volvo Cars to open new software development facility in Poland
Volvo Cars is to open a brand-new Tech Hub in Krakow, Poland’s second-largest city. The facility will be a key software development centre and play a crucial role in Volvo’s strategic ambition to be a fully electric brand by 2030 and a leader in new technology, not least through in-house software development. The Tech hub… Continue reading Volvo Cars to open new software development facility in Poland
Biologics License Application for lecanemab designated for Priority Review by China National Medical Products Administration
STOCKHOLM, Feb. 28, 2023 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for lecanemab (brand name in the U.S.: LEQEMBI™), an investigational anti-amyloid beta (Aβ) protofibril antibody has been designated for Priority Review by the National Medical Products Administration (NMPA) in China. The Priority Review… Continue reading Biologics License Application for lecanemab designated for Priority Review by China National Medical Products Administration
Biologics License Application for lecanemab designated for Priority Review by China National Medical Products Administration
STOCKHOLM, Feb. 28, 2023 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for lecanemab (brand name in the U.S.: LEQEMBI™), an investigational anti-amyloid beta (Aβ) protofibril antibody has been designated for Priority Review by the National Medical Products Administration (NMPA) in China. The Priority Review… Continue reading Biologics License Application for lecanemab designated for Priority Review by China National Medical Products Administration